Clinical Trials Using Recombinant Human Papillomavirus Nonavalent Vaccine
Clinical trials are research studies that involve people. The clinical trials on this list are studying Recombinant Human Papillomavirus Nonavalent Vaccine. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
HPV Vaccine Therapy in Interrupting Progression in Patients with High-Grade Vulvar or Anal Lesions
This randomized phase IV trial studies how well human papillomavirus (HPV) vaccine therapy works in interrupting progression in patients with high-grade vulvar or anal lesions. Vaccines made from HPV peptides or antigens may help the body build an effective immune response to kill tumor cells and decrease the chance of vulvar or anal lesions to progress or come back.
Location: Fred Hutch / University of Washington Cancer Consortium, Seattle, Washington
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial
This phase II trial studies how well a nonavalent human papillomavirus vaccine works in preventing human papillomavirus-related cancer in adult women prior to living donor kidney transplantation. Vaccines made from peptides of human papillomavirus may help the body build an effective immune response to kill tumor cells. Giving booster vaccinations may make a stronger immune response and prevent or delay the recurrence of cancer.
Location: 5 locations
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients with HIV and HPV
This randomized phase III trial studies how well human papillomavirus (HPV) vaccine therapy works in reducing high-grade cervical lesions in patients with human immunodeficiency virus (HIV) and HPV. Vaccines made from HPV peptides or antigens may help the body build an effective immune response to kill the HPV virus and prevent cervical lesions from developing or coming back after being removed.
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina